Singapur - İngilizce - HSA (Health Sciences Authority)

organon singapore pte. ltd. - formoterol fumarate, dihydrate; mometasone furoate - aerosol, metered - 0.0061mg - formoterol fumarate, dihydrate 0.0061mg; mometasone furoate 0.1210mg

Singapur - İngilizce - HSA (Health Sciences Authority)

organon singapore pte. ltd. - formoterol fumarate, dihydrate; mometasone furoate - aerosol, metered - 0.0061mg - formoterol fumarate, dihydrate 0.0061mg; mometasone furoate 0.2420mg

Singapur - İngilizce - HSA (Health Sciences Authority)

organon singapore pte. ltd. - formoterol fumarate, dihydrate; mometasone furoate - aerosol, metered - 0.0061mg - formoterol fumarate, dihydrate 0.0061mg; mometasone furoate 0.0605mg

Kanada - İngilizce - Health Canada

ratiopharm inc division of teva canada limited - salbutamol - metered-dose aerosol - 100mcg - salbutamol 100mcg - selective beta 2-adrenergic agonists

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

rex medical ltd - salbutamol sulfate 0.12mg equivalent to 100 mcg salbutamol - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 0.12mg equivalent to 100 mcg salbutamol excipient: ethanol norflurane oleic acid - salbutamol sulphate is indicated for the prevention and treatment of bronchospasm and acts on the ?2 (beta-2) adrenoceptors of bronchial muscle at therapeutic doses, with little or no action on the ?1 (beta-1) adrenoceptors of the heart. with its fast onset of action, it is particularly suitable for the management and prevention of attack in mild asthma and for the treatment of acute exacerbations in moderate to severe asthma. patients with unstable or severe asthma should not rely on bronchodilators as the main or only form of treatment. severe asthma requires regular medical assessment as death may occur. patients with severe asthma have constant symptoms and frequent exacerbations, with limited physical capacity, and pef values below 60% (predicted at baseline) with greater than 30% variability, usually not returning entirely to normal after a bronchodiliator. together with corticosteroid treatment, salair inhaler provides essential rescue medication for severe asthmatics in treating acute exacerbations. urgent treatment and medical advice is required immediately - if the patient fails to respond rapidly or fully to the rescue medication. salair provides short-acting (4-6 hours) bronchodiliation with fast onset in reversible airways obstruction disease appropriate for emphysema, asthma and chronic bronchitis. it is suitable for long-term use in the relief and prevention of asthma symptoms. salair should be utilized to alleviate symptoms when they happen and to prevent them in those circumstances recognised by the patient to precipitate an asthmatic attack (e.g. before exercise or unavoidable allergen exposure). salair is particularly valuable as rescue medication in mild, moderate or severe asthma, provided that reliance on it does not delay the introduction and use of regular inhaled corticosteroid therapy.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - salbutamol sulfate 120.5ug equivalent to 100 µg dose (10% excess may be added to compensate for manufacturing loss);   - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120.5ug equivalent to 100 µg dose (10% excess may be added to compensate for manufacturing loss)   excipient: norflurane - salbutamol is a selective ?2 adrenoceptor agonist indicated for the treatment or prevention of bronchospasm. it provides short acting (four hours) bronchodilation in reversible airways obstruction due to asthma, chronic bronchitis and emphysema. for patients with asthma salbutamol may be used to relieve symptoms when they occur and to prevent them prior to a known trigger. bronchodilators should not be the only or main treatment in patients with persistent asthma. in patients with persistent asthma unresponsive to salbutamol, treatment with inhaled corticosteroids is recommended to achieve and maintain control. failure to respond promptly or fully to such rescue medication signals a need for urgent medical advice and treatment.

Malta - İngilizce - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - salbutamol - pressurised inhalation - salbutamol 100 µg - drugs for obstructive airway diseases

Kanada - İngilizce - Health Canada

boehringer ingelheim (canada) ltd ltee - ipratropium bromide; salbutamol sulfate - metered-dose aerosol - 20mcg; 120mcg - ipratropium bromide 20mcg; salbutamol sulfate 120mcg - antimuscarinics antispasmodics

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

norton healthcare limited t/a ivax pharmaceuticals uk - salbutamol sulfate - nebuliser solution - 2.5/2.5 mg/ml - salbutamol

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

norton healthcare limited t/a ivax pharmaceuticals uk - salbutamol - nebuliser solution - 5/2.5 mg/ml - salbutamol